FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake

LONDON (Reuters) – Johnson & Johnson is in talks with multiple governments and global organizations as it seeks to develop a COVID-19 vaccine, it said on Thursday after Reuters reported that the U.S. company is in talks over a potential EU supply deal.

“We are committed to making our COVID-19 vaccine accessible globally to populations at greatest risk and where it could provide the greatest good according to our vaccine’s profile,” a Johnson & Johnson spokesman said in an email.

“As part of that, we are in ongoing discussions with many stakeholders, including national governments and global organizations.”

Reporting by Josephine Mason; Editing by David Goodman

Products You May Like

Articles You May Like

One in 20 UK workers return from furlough in recent weeks
Primark the star attraction as England’s stores reopen after lockdown
Films aiming to win Oscars will need to meet diversity criteria, Academy says
In landmark ruling, Supreme Court bars discrimination against LGBT workers
U.S. airlines threaten to ban passengers who refuse to wear masks

Leave a Reply

Your email address will not be published. Required fields are marked *